Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
Clinical trial NCT04417621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04417621
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2027-02-02
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.